Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
ALLENA PHARMACEUTICALS INC Share · US0181191075 · ALNA · A2H8TL (XNAS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ALLENA PHARMACEUTICALS INC
Analyst Grade Summary
No Price
Company Profile for ALLENA PHARMACEUTICALS INC Share
Allena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. Its lead product candidate is ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and gout in the setting of advanced chronic kidney disease. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.
Company Data
Name ALLENA PHARMACEUTICALS INC
Company Allena Pharmaceuticals, Inc.
Symbol ALNA
Website
https://www.allenapharma.com
Primary Exchange 
NASDAQ
NASDAQ
WKN A2H8TL
ISIN US0181191075
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Louis Brenner
Country United States of America
Currency USD
Employees 0,0 T
Address 1 Newton Executive Park Ste 202, 02462 Newton
IPO Date 2017-11-02
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | ALNA |
More Shares
Investors who hold ALLENA PHARMACEUTICALS INC also have the following shares in their portfolio:
